期刊文献+
共找到274篇文章
< 1 2 14 >
每页显示 20 50 100
Clinical experience sharing on gastric microneuroendocrine tumors: A case report
1
作者 You-Jun Wang Da-Ming Fan +2 位作者 Yu-Shuang Xu Qi Zhao Zhen-Fang Li 《World Journal of Clinical Cases》 SCIE 2024年第4期795-800,共6页
BACKGROUND The majority of gastric neuroendocrine tumors(G-NENs)are present in various lesions under endoscopy,and they can be polypoid uplifts,submucosal tumors or papules,erosions,and ulcers.The lesions are mostly c... BACKGROUND The majority of gastric neuroendocrine tumors(G-NENs)are present in various lesions under endoscopy,and they can be polypoid uplifts,submucosal tumors or papules,erosions,and ulcers.The lesions are mostly confined to the mucosal or submucosal layer,usually less than 2 cm,and exclusively localized to the gastric body or fundus.In type 1 G-NENs,about 22%of cases have no visible lesions under an endoscope,and such lesions can only be detected via biopsies(microcar-cinoids).CONCLUSION In the case under study,the patient did not have any visible raised lesions under a gastroscope,and the lesions were found only after a random biopsy.This article combines the endoscopic manifestations and clinical features of the lesions in this case to improve the diagnosis of G-NENs. 展开更多
关键词 Neuroendocrine tumor micro carcinoids ENDOSCOPY Case report
下载PDF
Comparison of Multimodality Image-Based Volumes in Preclinical Tumor Models Using <i>In-Air</i>Micro-CT Image Volume as Reference Tumor Volume 被引量:2
2
作者 Yongsook C. Lee Gary D. Fullerton Beth A. Goins 《Open Journal of Medical Imaging》 2015年第3期117-132,共16页
Purpose: Changes in tumor volume are used for therapy response monitoring in preclinical studies. Unlike prior studies, this article introduces in-air micro-computed tomography (micro-CT) image volume as reference tum... Purpose: Changes in tumor volume are used for therapy response monitoring in preclinical studies. Unlike prior studies, this article introduces in-air micro-computed tomography (micro-CT) image volume as reference tumor volume in rodent tumor models. Tumor volumes determined using imaging modalities such as magnetic resonance imaging (MRI), micro-CT and ultrasound (US), and with an external caliper are compared with the reference tumor volume. Materials and Methods: In vivo MR, US and micro-CT imaging was performed 4, 6, 9, 11 and 13 days after tumor cell inoculation into nude rats. On the day of the imaging study, in vivo caliper measurements were also made. After in vivo imaging, tumors were excised followed by in-air micro-CT imaging and ex vivo caliper measurements of excised tumors. The in-air micro-CT image volume of excised tumors was determined as reference tumor volume. Then tumor volumes were calculated using formula V = (π/6) × a × b × c, where a, b and c are maximum diameters in three perpendicular dimensions determined by the three image modalities and caliper, and compared with reference tumor volume by linear regression analysis as well as Bland-Altman plots. Results: The correlation coefficients (R2) of the regression lines for in vivo tumor volumes measured by the three imaging modalities were 0.9939, 0.9669 and 0.9806 for MRI, US and micro-CT respectively. For caliper measurements, the coefficients were 0.9274 and 0.9819 for caliperin vivo and caliperex vivo respectively. In Bland-Altman plots, the average of tumor volume difference from reference tumor volume (bias) was significant for caliper and micro-CT, but not for MRI and US. Conclusion: Using the in-air micro-CT image volume as reference tumor volume, tumor volume measured by MRI was the most accurate among the three imaging modalities. In vivo caliper volume measurements showed unreliability while ex vivo caliper measurements reduced errors. 展开更多
关键词 In-Air micro-CT Magnetic Resonance Imaging Ultrasound CALIPER tumor VOLUME Measurements
下载PDF
Experimental Study of A Novel Piezoelectric Tumor Marker Micro-array Immunosensor
3
作者 Bo Zhang Weiling Fu +3 位作者 Xue Zhang Qinghai Chen Shijun Xu Daihua Tang 《稀有金属材料与工程》 SCIE EI CAS CSCD 北大核心 2006年第A03期405-408,共4页
A novel 2×5 model of insert-plug piezoelectric quartz crystal tumor marker micro-array immunosensor constructed with screw clamp apparatus has been developed for quantitative detection of the tumor markers such a... A novel 2×5 model of insert-plug piezoelectric quartz crystal tumor marker micro-array immunosensor constructed with screw clamp apparatus has been developed for quantitative detection of the tumor markers such as alpha-fetoprotein (AFP),carcino-embryonic antigen (CEA),prostate specific antigen (PSA),and human chorionic gonadotropin (hCG) in serum,in which every crystal unit can oscillate independently with the stability of±1 hertz (Hz) in air and±2 Hz in liquid.These response characteristics of Pz tumor marker micro-array immunosensor such as temperature, time-cost,reproducibility and specificity etc were also investigated.The detection ranges for AFP,CEA,PSA,and hCG obtained by Pz micro-array immunosensor were 20 ng/ml~640 ng/ml,1.56 ng/ml~50 ng/ml,1.25 ng/ml~50 ng/ml,and 2.5 mIU/ml~250 mlU/mi respectively with the coefficient of variance (CV) less than 5%.No cross-reactivates with other tumor markers in serum were observed.The results of AFP,CEA,PSA,and hCG obtained by this method from 68 serum samples were in good agreement with those given by chemiluminescence immunoassay with the correlation coefficients of 0.92,0.90,0.91,and 0.94 respectively.The Pz immunosensor regenerated by urea solution could be reused for five times without appreciable loss of response activity.Therefore,the proposed insert-plug immunosensor provides a rapid, sensitive,specific,reusable,convenient and reliable alternative for the detection of tumor markers in clinical laboratory. 展开更多
关键词 piezoelectric immunosensor micro-ARRAY tumor maker
下载PDF
外泌体源性microRNA在疾病诊疗中的研究进展 被引量:13
4
作者 唐慧 伍海姗 +2 位作者 杨怡 赵靖平 陈晋东 《中南大学学报(医学版)》 CAS CSCD 北大核心 2015年第11期1270-1275,共6页
外泌体是一种纳米级别的生物膜结构,由机体的多种细胞分泌,广泛分布于唾液、血浆、乳汁等体液中。外泌体中有蛋白质、m RNA、microRNA、细胞因子、转录因子受体等多种生物活性物质。microRNA是短链非编码RNA,在转录后水平调节基因的表达... 外泌体是一种纳米级别的生物膜结构,由机体的多种细胞分泌,广泛分布于唾液、血浆、乳汁等体液中。外泌体中有蛋白质、m RNA、microRNA、细胞因子、转录因子受体等多种生物活性物质。microRNA是短链非编码RNA,在转录后水平调节基因的表达,广泛参与个体发育、细胞增殖凋亡等生命活动。外泌体源性microRNA具有生物学特性和靶向特异性,不仅可作为肿瘤、神经退行性病变、重大精神疾病的分子诊断标志物,甚至有潜力成为上述疾病的新治疗靶点。 展开更多
关键词 外泌体 microRNA 肿瘤 神经系统疾病 精神疾病
下载PDF
^(18)F-FMISO的自动化合成改进及其肿瘤乏氧Micro-PET/CT显像 被引量:5
5
作者 王明伟 张勇平 +2 位作者 郑宇佳 鲍晓 章英剑 《核技术》 CAS CSCD 北大核心 2013年第10期38-43,共6页
1-H-1-(3-[18F]氟-2-羟基丙基)-2-硝基咪唑(18F-FMISO)是特异性肿瘤乏氧分子影像探针,其PET/CT显像指导肿瘤放疗靶区的勾画具有重要的临床应用价值。本文旨在建立18F-FMISO的改进的自动化合成方法,开展其肿瘤乏氧Micro-PET/CT显像研究... 1-H-1-(3-[18F]氟-2-羟基丙基)-2-硝基咪唑(18F-FMISO)是特异性肿瘤乏氧分子影像探针,其PET/CT显像指导肿瘤放疗靶区的勾画具有重要的临床应用价值。本文旨在建立18F-FMISO的改进的自动化合成方法,开展其肿瘤乏氧Micro-PET/CT显像研究。基于标记前体NITTP和简便的"一锅法",利用升级、改进的Explora GN模块,依次完成放射氟化反应(NITTP(10 mg),MeCN(1.0 mL),120 oC,5.0 min)、水解反应(HCl(1.0 mol/L,1.0 mL),130 oC,8.0 min)和HPLC分离纯化,自动化合成18F-FMISO。同时,采取分析型Radio-HPLC和Radio-TLC等方法检测各项质量控制指标,利用Micro-PET/CT进行荷SW1990胰腺肿瘤乏氧显像实验。结果表明,18F-FMISO的自动化生产时间约为65 min,放射化学产率为(30 5.0)%(未衰变校正,n=20),放射化学纯度大于99%,比活度为(2.04 0.17)×1011Bq·mol–1,化学纯度得到改善。Micro-PET/CT显像表明,18F-FMISO在荷SW1990瘤鼠体内均呈全身分布,最佳的肿瘤乏氧显像时间为注射后3.0 h,肿瘤/肌肉吸收比为3.00 0.08。本研究建立了基于HPLC分离纯化而改进的18F-FMISO的自动化合成方法,而且其Micro-PET/CT肿瘤乏氧显像对比度高,为乏氧显像研究提供了可靠的制备方法和基本的实验参考依据。 展开更多
关键词 18F-FMISO 肿瘤乏氧显像 自动化合成 HPLC分离 micro-PET/CT
下载PDF
Micro-PET在膈下逐瘀汤抑制肝细胞癌研究中的应用 被引量:1
6
作者 蔡刚明 赵韬 +2 位作者 张汀荣 顾晓波 黄洪波 《临床肿瘤学杂志》 CAS 2017年第10期880-884,共5页
目的采用micro-PET显像技术评判中药复方膈下逐淤汤对荷肝细胞癌裸鼠的抑制作用。方法 20周龄健康裸鼠12只,随机分为给药组与对照组(n=6),皮下接种人肝癌细胞Bel7402建立荷瘤模型。接种1周后每日灌胃膈下逐淤汤0.3 ml,对照组给予等体积... 目的采用micro-PET显像技术评判中药复方膈下逐淤汤对荷肝细胞癌裸鼠的抑制作用。方法 20周龄健康裸鼠12只,随机分为给药组与对照组(n=6),皮下接种人肝癌细胞Bel7402建立荷瘤模型。接种1周后每日灌胃膈下逐淤汤0.3 ml,对照组给予等体积生理盐水,连续给药60 d。待肿瘤长至约5 mm时测量肿瘤体积,每周2次,计算瘤体积大小和抑瘤率并绘制肿瘤生长曲线。给药24、60 d后分别行^(18)F-FDG、^(18)F-RGD micro-PET扫描各一次,测定肿瘤组织摄取量、标准摄取值(SUV)及肿瘤/肌肉靶本比(T/NT)。结果接种24 d后,肿瘤生长至5 mm,给药组瘤体积(74.8 mm^3)小于对照组(78.3mm^3)。^(18)F-FDG micro-PET扫描给药组的肿瘤组织摄取量、SUV_(mean)和T/NT分别为(5.54±1.59)%ID/g、0.93±0.20和8.20±2.52,略小于对照组(5.92±1.23)%ID/g、1.00±0.19和8.71±2.36(P>0.05)。^(18)F-RGD micro-PET扫描给药组的肿瘤组织摄取量、SUV和T/NT分别为(4.08±0.64)%ID/g、0.75±0.08和6.91±0.72,略小于对照组(4.61±1.08)%ID/g、0.87±0.16和7.00±1.40(P>0.05)。接种60 d后,给药组和对照组的肿瘤体积分别增长至1854.4 mm^3和1462.9 mm^3。^(18)F-FDG micro-PET扫描给药组的肿瘤组织摄取量、SUV和T/NT分别为(3.56±0.54)%ID/g、0.70±0.09和4.91±0.92(n=5),大于对照组的3.28%ID/g、0.60和3.98(n=1)。^(18)F-RGD micro-PET扫描给药组的肿瘤组织摄取量、SUV和T/NT分别为(2.19±0.16)%ID/g、0.51±0.04和4.15±0.57(n=4)。给药组和对照组的肿瘤重量分别为(1.93±0.95)g(n=5)和1.69 g(n=1),抑瘤率为-14.76%。给药组的中位生存时间为60 d,长于对照组的40.5 d,差异有统计学意义(P<0.05)。结论膈下逐淤汤可能通过抑制葡萄糖的吸收和新生血管的生成来延长荷肝细胞癌裸鼠的生存时间。Micro-PET能动态地定量分析活体动物模型的生理、生化变化,可用于评价抗肿瘤药物的体内疗效。 展开更多
关键词 肝细胞癌 膈下逐淤汤 微型正电子断层扫描仪 ^18F-FDG ^18F-RGD 靶本比
下载PDF
MicroRNA-135在肿瘤中的研究进展
7
作者 汪康宁 邱明宁 +1 位作者 柳建军 陈合格 《肿瘤防治研究》 CAS CSCD 北大核心 2015年第10期1031-1036,共6页
Mircro RNA(mi RNAs)通过与信使RNA(m RNA)的序列互补来降解靶m RNA并抑制蛋白质翻译,在细胞增殖、分化、发育和凋亡等方面起着重要的作用。许多mi RNA可作为原癌基因或抑癌基因,在肿瘤的发生和发展中发挥重要作用。越来越多的研究表明,... Mircro RNA(mi RNAs)通过与信使RNA(m RNA)的序列互补来降解靶m RNA并抑制蛋白质翻译,在细胞增殖、分化、发育和凋亡等方面起着重要的作用。许多mi RNA可作为原癌基因或抑癌基因,在肿瘤的发生和发展中发挥重要作用。越来越多的研究表明,微mi R-135(mi R-135)与肿瘤的发生发展密切相关,本文主要对近年来mi R-135参与调节肿瘤细胞增殖、凋亡、侵袭、转移、耐药和预后等方面的机制作一综述,期望能对肿瘤的早期诊断、治疗和预后判断有所帮助。 展开更多
关键词 MI RNA-135 微RNAS 肿瘤 耐药 预后
下载PDF
外泌体中microRNAs在神经胶质瘤中的研究进展
8
作者 冯瑞 王春红 +2 位作者 成睿 张爱荣 吉宏明 《临床神经外科杂志》 2022年第5期591-593,597,共4页
外泌体是一种膜源性囊泡,在尿液、精液、血液、眼泪、淋巴液、脑脊液等体液中稳定存在。在电子显微镜下,它们呈杯状或碟状。一般尺寸在25~100 nm左右。人体内的各种细胞可以释放不同类型的外泌体,其中包含microRNA、mRNA、蛋白质和其他... 外泌体是一种膜源性囊泡,在尿液、精液、血液、眼泪、淋巴液、脑脊液等体液中稳定存在。在电子显微镜下,它们呈杯状或碟状。一般尺寸在25~100 nm左右。人体内的各种细胞可以释放不同类型的外泌体,其中包含microRNA、mRNA、蛋白质和其他遗传物质,其在细胞通讯中起重要作用,尤其是在调控细胞的生长,构建细胞生长环境等方面。本文针对外泌体中的microRNA在胶质瘤的相关方面进行总结。 展开更多
关键词 外泌体 胶质瘤 microRNAS 肿瘤微环境 治疗
下载PDF
MicroRNA-24的研究进展 被引量:2
9
作者 刘懿霄 马韵 龙喜带 《世界华人消化杂志》 CAS 北大核心 2014年第33期5106-5113,共8页
Micro RNA(mi RNA,mi R)是一种内源性、非编码蛋白质的小分子单链RNA,长度为18-24个核苷酸,与组织器官发育、细胞增殖、分化和凋亡以及肿瘤的发生发展有关.本文主要对mi R-24的生物学特性与其在肿瘤及非肿瘤性疾病中可能发挥的调节作用... Micro RNA(mi RNA,mi R)是一种内源性、非编码蛋白质的小分子单链RNA,长度为18-24个核苷酸,与组织器官发育、细胞增殖、分化和凋亡以及肿瘤的发生发展有关.本文主要对mi R-24的生物学特性与其在肿瘤及非肿瘤性疾病中可能发挥的调节作用作一综述,可为临床诊断和治疗方面提供新的线索,以降低患者的病死率. 展开更多
关键词 micro RNA-24 细胞周期 细胞分化 肿瘤
下载PDF
^(18)F-FDG、^(18)F-RGD和^(18)F-FET在LN229脑胶质模型体内生物分布和Micro-PET显像 被引量:6
10
作者 高霞 张斌 +2 位作者 王斌 黄洪波 李新平 《同位素》 CAS 2015年第3期155-159,共5页
为研究肿瘤显像剂18F-FDG、18F-RGD和18F-FET在LN229脑胶质瘤模型裸鼠体内分布和MicroPET肿瘤显像,采用酪氨酸和NOTA修饰的[c(RGDyK)]2为前体分别合成18 F-FET和18 F-RGD;颅内注射LN229细胞建立脑胶质瘤模型,研究18F-FDG、18F-RGD和18F-... 为研究肿瘤显像剂18F-FDG、18F-RGD和18F-FET在LN229脑胶质瘤模型裸鼠体内分布和MicroPET肿瘤显像,采用酪氨酸和NOTA修饰的[c(RGDyK)]2为前体分别合成18 F-FET和18 F-RGD;颅内注射LN229细胞建立脑胶质瘤模型,研究18F-FDG、18F-RGD和18F-FET在注射30min和60min体内脏器分布以及荷瘤鼠Micro-PET显像。结果表明,18 F-FET和18 F-RGD放化纯度大于95%。荷瘤鼠体内分布显示,注射后1h,18 F-FDG、18 F-RGD和18 F-FET在脑胶质瘤和脑组织内(括号内)的摄取分别为(4.89±0.65)%ID/g((2.72±0.76)%ID/g)、(2.10±0.32)%ID/g((0.23±0.01)%ID/g)、(3.02±0.64)%ID/g((0.74±0.12)%ID/g),18F-FDG、18F-RGD和18F-FET在肿瘤和脑摄取放射性比值分别为0.64±0.07(1.80±0.32)、8.22±1.03(9.13±1.21)和2.15±0.48(4.08±0.92),Micro-PET肿瘤显像清晰。结果提示,18F-FET和18F-RGD更适用于脑胶质瘤的诊断。 展开更多
关键词 脑胶质瘤 micro-PET显像 O-(2-18F-氟代乙基)-L-酪氨酸
下载PDF
microRNA联合PET-CT对头颈部鳞状细胞癌术后转移的诊断价值 被引量:2
11
作者 许彤 阎慧丽 许挺 《中国医疗设备》 2015年第10期51-54,共4页
目的探讨一种新型microRNA试剂盒联合正电子发射断层/计算机断层扫描(PET/CT)对头颈部鳞状细胞癌术后转移的诊断价值。方法选取40例行全身PET/CT检查的头颈部鳞状细胞癌术后病例,提取外周血标本,应用包含4种microRNAs的试剂盒诊断肿瘤... 目的探讨一种新型microRNA试剂盒联合正电子发射断层/计算机断层扫描(PET/CT)对头颈部鳞状细胞癌术后转移的诊断价值。方法选取40例行全身PET/CT检查的头颈部鳞状细胞癌术后病例,提取外周血标本,应用包含4种microRNAs的试剂盒诊断肿瘤术后转移,并与病理诊断结果进行比较,分析两种检查方法及联合检查的敏感性、特异性及准确性。结果 40例病例中,28例经病理诊断为头颈部鳞状细胞癌转移。micro RNA试剂盒诊断头颈部鳞状细胞癌术后转移的灵敏度为96.43%,特异度为83.33%,准确度为92.50%;PET/CT诊断的灵敏度为89.29%,特异度为91.67%,准确度为90.00%;两者联合诊断的灵敏度为100%,特异度为83.33%,准确度为95.00%。结论 PET/CT诊断头颈部鳞状细胞癌术后转移的特异性较microRNA试剂盒高,而敏感性不足,microRNA试剂盒对PET/CT诊断具有补充作用,两者联合应用是诊断头颈部鳞状细胞癌术后转移的更为理想的方法。 展开更多
关键词 头颈部鳞状细胞癌 正电子发射断层/计算机断层扫描 肿瘤标志物
下载PDF
MicroRNA aberrations:An emerging field for gallbladdercancer management 被引量:16
12
作者 Vishal Chandra Jong Joo Kim +1 位作者 Balraj Mittal Rajani Rai 《World Journal of Gastroenterology》 SCIE CAS 2016年第5期1787-1799,共13页
Gallbladder cancer(GBC) is infrequent but most lethal biliary tract malignancy characterized by an advanced stage diagnosis and poor survival rates attributed to absence of specific symptoms and effective treatment op... Gallbladder cancer(GBC) is infrequent but most lethal biliary tract malignancy characterized by an advanced stage diagnosis and poor survival rates attributed to absence of specific symptoms and effective treatment options. These necessitate development of early prognostic/predictive markers and novel therapeutic interventions. Micro RNAs(mi RNAs) are small, noncoding RNA molecules that play a key role in tumor biology by functioning like tumor suppressor- or oncogenes and their aberrant expression are associated with the pathogenesis of several neoplasms with overwhelming clinical implications. Since mi RNA signature is tissue specific, here, we focused on current data concerning the mi RNAs abberations in GBC pathogenesis. In GBC, mi RNAs with tumor suppressor activity(mi R-135-5p, mi R-335, mi R-34 a, mi R-26 a, mi R-146b-5p, Mir-218-5p, mi R-1, mi R-145, mir-130a) were found downregulated, while those with oncogenic property(mi R-20 a, mi R-182, mir-155) were upregulated. The expression profile of mi RNAs was significantly associated with GBC prognosis and prediction, and forced over-expression/ inhibition of these mi RNAs was shown to affect tumor growth and development. Further, differential expression of mi RNAs in the blood samples of GBC patients suggest mi RNAs as promising noninvasive biomarker. Thus, mi RNAs represent potential candidate for GBC management, though many hurdles need to be overcome before mi RNAs therapy can be clinically applied to GBC prevention and treatment. 展开更多
关键词 GALLBLADDER cancer microRNA ABERRATIONS tumor SUPPRESSOR gene ONCOGENE BIOMARKER Therapy
下载PDF
Multi-modality measurement and comprehensive analysis of hepatocellular carcinoma using synchrotron-based microscopy and spectroscopy 被引量:1
13
作者 Gong-Xiang Wei Sui-Xia Zhang +4 位作者 Zhao Li Fu-Li Wang Yan-Ling Xue Te Ji Hui-Qiang Liu 《Nuclear Science and Techniques》 SCIE EI CAS CSCD 2021年第9期136-149,共14页
The visualization and data mining of tumor multidimensional information may play a major role in the analysis of the growth,metastasis,and microenvironmental changes of tumors while challenging traditional imaging and... The visualization and data mining of tumor multidimensional information may play a major role in the analysis of the growth,metastasis,and microenvironmental changes of tumors while challenging traditional imaging and data processing techniques.In this study,a general trans-scale and multi-modality measurement method was developed for the quantitative diagnosis of hepatocellular carcinoma(HCC)using a combination of propagation-based phase-contrast computed tomography(PPCT),scanning transmission soft X-ray microscopy(STXM),and Fourier transform infrared micro-spectroscopy(FTIR).Our experimental results reveal the trans-scale micro-morpho-logical HCC pathology and facilitate quantitative data analysis and comprehensive assessment.These results include some visualization features of PPCT-based tissue microenvironments,STXM-based cellular fine structures,and FTIR-based bio-macromolecular spectral characteris-tics during HCC tumor differentiation and proliferation.The proposed method provides multidimensional feature data support for constructing a high-accuracy machine learning algorithm based on a gray-level histogram,gray-gradient co-occurrence matrix,gray-level co-occurrence matrix,and back-propagation neural network model.Multi-dimensional information analysis and diagnosis revealed the morphological pathways of HCC pathological evolution and we explored the relationships between HCC-related feature changes in inflammatory microenviron-ments,cellular metabolism,and the stretching vibration peaks of biomolecules of lipids,proteins,and nucleic acids.Therefore,the proposed methodology has strong potential for the visualization of complex tumors and assessing the risks of tumor differentiation and metastasis. 展开更多
关键词 Propagation based phase contrast tomography Soft X-ray microscopy Infrared micro spectroscopy Machine learning tumor microenvironment and metastasis
下载PDF
基于Micro-CT成像对肝癌原位移植瘤血管三维结构的定量研究 被引量:1
14
作者 刘巧遇 李若坤 《肝脏》 2020年第12期1290-1293,共4页
目的基于Micro-CT成像定量肝癌裸鼠原位移植瘤血管的三维结构特征。方法采用雄性Balb/c裸小鼠20只,随机分为肝癌组(n=10)和正常对照组(n=10),肝癌组采用MHCC97H人肝癌细胞株构建原位移植瘤模型,正常对照组肝内注射同等量0.9%氯化钠溶液... 目的基于Micro-CT成像定量肝癌裸鼠原位移植瘤血管的三维结构特征。方法采用雄性Balb/c裸小鼠20只,随机分为肝癌组(n=10)和正常对照组(n=10),肝癌组采用MHCC97H人肝癌细胞株构建原位移植瘤模型,正常对照组肝内注射同等量0.9%氯化钠溶液。造模21 d后进行目标血管铸型和Micro-CT扫描,重建血管图像,观察肝癌和正常肝脏血管的三维形态并定量分析血管密度特征、血管形态特征上的差异。结果正常肝脏血管呈树枝状逐级分支,走行自然;肝癌血管分布杂乱,形态不规则。定量分析结果显示,相比于正常肝脏,肝癌的血管占比[(5.57±1.16)%比(14.29±2.89)%,P<0.01]、血管分支密度[(3.86±1.15)比(7.25±3.30),P=0.007]明显降低,平均半径缩小[(0.17±0.03)mm比(0.22±0.04)mm,P=0.004],平均DF[(1.20±0.01)比(1.16±0.00),P<0.01]、平均SOAM[(4.56±0.10)rad/mm比(4.33±0.20)rad/mm,P=0.004]增加,平均血管分支长度略缩短但差异无统计学意义(P>0.05)。结论基于Micro-CT的成像展示了肝癌原位移植瘤血管的三维结构,通过量化肝癌和健康肝脏的血管特征差异,可以进一步明确抑制肿瘤血液供应的潜在途径。 展开更多
关键词 肝癌 原位移植瘤 micro-CT 定量分析
下载PDF
Micro RNAs: Novel immunotherapeutic targets in colorectal carcinoma 被引量:6
15
作者 Xiang Li Jing Nie +1 位作者 Qian Mei Wei-Dong Han 《World Journal of Gastroenterology》 SCIE CAS 2016年第23期5317-5331,共15页
Colorectal carcinoma(CRC) is one of the most common types of cancer worldwide and the prognosis for CRC patients with recurrence or metastasis is extremely poor. Although chemotherapy and radiation therapy can improve... Colorectal carcinoma(CRC) is one of the most common types of cancer worldwide and the prognosis for CRC patients with recurrence or metastasis is extremely poor. Although chemotherapy and radiation therapy can improve survival, there are still numerous efforts to be performed. Immunotherapy is frequently used, either alone or in combination with other therapies, for the treatment of CRC and is a safe and feasible way to improve CRC treatment. Furthermore, the significance of the immune system in the biology of CRC has been demonstrated by retrospective assessments of immune infiltrates in resected CRC tumors. Micro RNAs(mi RNAs) are short, non-coding RNAs that can regulate multiple target genes at the post-transcriptional level and play critical roles in cell proliferation, differentiation and apoptosis. Mi RNAs are required for normal immune system development and function. Nevertheless, aberrant expression of mi RNAs is often observed in various tumor types and leads to immune disorders or immune evasion. The immunomodulatory function of mi RNAs indicates that mi RNAs may ultimately be part of the portfolio of anti-cancer targets. Herein, we will review the potential roles of mi RNAs in the regulation of the immune response in CRC and then move on to discuss how to utilize different mi RNA targets to treat CRC. We also provide an overview of the major limitations and challenges of using mi RNAs as immunotherapeutic targets. 展开更多
关键词 Colorectal carcinoma microRNAS tumor microenvironment IMMUNOTHERAPY INFLAMMATION Inflammatory bowel disease Immune response
下载PDF
Micro RNA-331 inhibits development of gastric cancer through targeting musashi1 被引量:3
16
作者 Lei-Ying Yang Guang-Le Song +3 位作者 Xiao-Qian Zhai Li Wang Qin-Lai Liu Ming-Shun Zhou 《World Journal of Gastrointestinal Oncology》 SCIE CAS 2019年第9期705-716,共12页
BACKGROUND The molecular mechanisms involved in micro RNAs(mi RNAs)have been extensively investigated in gastric cancer(GC).However,how mi R-331 regulates GC pathogenesis remains unknown.AIM To illuminate the effect o... BACKGROUND The molecular mechanisms involved in micro RNAs(mi RNAs)have been extensively investigated in gastric cancer(GC).However,how mi R-331 regulates GC pathogenesis remains unknown.AIM To illuminate the effect of mi R-331 on cell metastasis and tumor growth in GC.METHODS The q RT-PCR,CCK8,Transwell,cell adhesion,Western blot,luciferase reporter and xenograft tumor formation assays were applied to explore the regulatory mechanism of mi R-331 in GC.RESULTS Downregulation of mi R-331 associated with poor prognosis was detected in GC.Functionally,mi R-331 suppressed cell proliferation,metastasis and tumor growth in GC.Further,mi R-331 was verified to directly target musashi1(MSI1).In addition,mi R-331 inversely regulated MSI1 expression in GC tissues.Furthermore,upregulation of MSI1 weakened the inhibitory effect of mi R-331 in GC.CONCLUSION mi R-331 inhibited development of GC through targeting MSI1,which may be used as an indicator for the prediction and prognosis of GC. 展开更多
关键词 microRNA-331 Musashi1 tumor growth METASTASIS GASTRIC cancer
下载PDF
Endoscopic mucosal resection for rectal carcinoids under micro-probe ultrasound guidance 被引量:6
17
作者 Fu-Run Zhou Liu-Ye Huang Cheng-Rong Wu 《World Journal of Gastroenterology》 SCIE CAS 2013年第16期2555-2559,共5页
AIM: To assess the therapeutic value of endoscopic mucosal resection (EMR) under micro-probe ultrasound guidance for rectal carcinoids less than 1 cm in diameter. METHODS: Twenty-one patients pathologically diagnosed ... AIM: To assess the therapeutic value of endoscopic mucosal resection (EMR) under micro-probe ultrasound guidance for rectal carcinoids less than 1 cm in diameter. METHODS: Twenty-one patients pathologically diagnosed with rectal carcinoids following colonoscopy in our hospital from January 2007 to November 2012 were included in this study. The patients consisted of 14 men and 7 women, with a mean age of 52.3 ± 12.2 years (range: 36-72 years). The patients with submucosal tumors less than 1 cm in diameter arising from the rectal and muscularis mucosa detected by micro-probe ultrasound were treated with EMR and followed up with conventional endoscopy and micro-probe ultrasound. RESULTS: All of the 21 tumors were confirmed by micro-probe ultrasound as uniform hypoechoic masses originating from the rectal and muscularis mucosa, without invasion of muscularis propria and vessels, and less than 1 cm in diameter. EMR was successfully completed without bleeding, perforation or other complications. The resected specimens were immunohistochemically confirmed to be carcinoids. Patients were followed up for one to two years, and no tumor recurrence was reported. CONCLUSION: EMR is a safe and effective treatment for rectal carcinoids less than 1 cm in diameter. 展开更多
关键词 micro-probe ultrasound ENDOSCOPIC MUCOSAL resection Rectal CARCINOID ENDOSCOPIC SUBMUCOSAL dissection SUBMUCOSAL tumors
下载PDF
Micro-RNAs as clinical biomarkers and therapeutic targets in breast cancer:Quo vadis? 被引量:4
18
作者 Gerasimos Socrates Christodoulatos Maria Dalamaga 《World Journal of Clinical Oncology》 CAS 2014年第2期71-81,共11页
Breast cancer(BC) is the most frequent type of non skin cancer among women and a major leading cause of cancer-related deaths in Western countries. It is substantial to discover novel biomarkers with diagnostic, progn... Breast cancer(BC) is the most frequent type of non skin cancer among women and a major leading cause of cancer-related deaths in Western countries. It is substantial to discover novel biomarkers with diagnostic, prognostic or predictive usefulness as well as therapeutic value for BC. Micro-RNAs(miR NAs) belong to a novel class of endogenous interfering RNAs that play a crucial role in post transcriptional gene silencing through m RNA targeting and, thus, are involved in many biological processes encompassing apoptosis,cell-cycle control, cell proliferation, DNA repair, immunity, metabolism, stress, aging, etc. Mi RNAs exert their action mainly in a tumor suppressive or oncogenic manner. The specific aberrant expression patterns of miR NAs in BC that are detected with the use of highthroughput technologies reflect their key role in cancer initiation, progression, migration, invasion and metastasis. The detection of circulating extracellular miR NAs in plasma of BC patients may provide novel, non-invasive biomarkers in favor of BC diagnosis and prognosis and,at the same time, accumulating evidence has underscored the possible contribution of miR NAs as valuable biomarkers to predict response to chemotherapy or radiotherapy. Data from in vitro and in vivo studies on BC have revealed promising therapeutic approaches via mi RNA delivery and mi RNA inhibition. The purpose of this review is to explore the ontological role of miR NAs in BC etiopathogenesis as well as to highlight their potential, not only as non-invasive circulating biomarkers with diagnostic and prognostic significance, but also as treatment response predictors and therapeutic targets aiding BC management. 展开更多
关键词 BIOMARKER Breast CANCER CANCER diagnosis micro-RNA ONCOGENE Therapy tumor SUPPRESSOR
下载PDF
一种改良的使用micro-CT扫描的肿瘤终末期小鼠血管造影方法
19
作者 魏艳 王淑敏 +1 位作者 张皓婉 徐小燕 《现代肿瘤医学》 CAS 2020年第16期2745-2748,共4页
目的:探讨裸鼠移植瘤模型中血管的分布和密度,试图改进造影剂注射方法来提高肿瘤部位造影剂灌注效率。方法:每只鼠麻醉后,于右侧皮下注射HCT-116细胞悬液,成瘤后定期测量肿瘤长径和短径。待裸鼠肿瘤负荷达到生命终结标准,肿瘤重量超过... 目的:探讨裸鼠移植瘤模型中血管的分布和密度,试图改进造影剂注射方法来提高肿瘤部位造影剂灌注效率。方法:每只鼠麻醉后,于右侧皮下注射HCT-116细胞悬液,成瘤后定期测量肿瘤长径和短径。待裸鼠肿瘤负荷达到生命终结标准,肿瘤重量超过体重的10%或者出现恶液质时,使用不同方法注射造影剂,应用微计算机断层扫描技术(micro-CT)进行造影,探究肿瘤的血管分布,比较不同注射方法的造影效率。结果:经比较,麻醉后,经下腔静脉注射造影剂的裸鼠造影效率显著高于尾静脉注射与腹腔注射,并且与尾静脉注射相比,对操作者的要求明显降低。结论:经下腔静脉注射造影剂后使用micro-CT造影可成为研究肿瘤终末期小鼠血供的有效方法,为观察肿瘤细胞对血管的调控提供证据。 展开更多
关键词 微计算机断层扫描技术 血管新生 肿瘤
下载PDF
抑制miRNA-376c-3p对肾透明细胞癌生长的影响 被引量:1
20
作者 镡云辉 赵蓉 +2 位作者 刘志明 卓奥 刘唐兴 《河北医药》 CAS 2024年第8期1132-1137,共6页
目的探究miRNA-376c-3对肾透明细胞癌(ccRCC)中肿瘤细胞生长的影响。方法以实时荧光定量PCR(RT-PCR)检测人ccRCC细胞系786-O、Caki-1、SN12-PM6、ACHN及正常人近段肾小管上皮细胞系HKC中miRNA-376c-3p的表达。体外培养786-O细胞,随机分... 目的探究miRNA-376c-3对肾透明细胞癌(ccRCC)中肿瘤细胞生长的影响。方法以实时荧光定量PCR(RT-PCR)检测人ccRCC细胞系786-O、Caki-1、SN12-PM6、ACHN及正常人近段肾小管上皮细胞系HKC中miRNA-376c-3p的表达。体外培养786-O细胞,随机分为对照组、miR-376c-3p inhibitor组(转染miR-376c-3p inhibitor)、miR-376c-3p mimics组(转染miR-376c-3p mimics)、阴性对照组(转染miR-376c-3p阴性对照),分组转染后以RT-PCR检测4组细胞miRNA-376c-3p表达;以Ki67免疫荧光染色、集落生成实验检测4组786-O细胞增殖;以TUNEL染色检测4组786-O细胞凋亡;以免疫荧光染色检测4组786-O细胞凋亡相关蛋白Bax、Bcl-2表达并比较其Bax/Bcl-2。于右腋窝皮下接种上述4组786-O细胞建立其裸鼠移植瘤模型,3周后测定其肿瘤体积与质量;以Ki67免疫荧光染色、TUNEL染色分别检测4组裸鼠肿瘤细胞增殖与凋亡。结果与HKC细胞比较,ccRCC细胞系786-O、Caki-1、SN12-PM6、ACHN中miR-376c-3p表达降低(P<0.05)。与对照组比较,miR-376c-3p inhibitor组细胞增殖率与集落形成率、肿瘤体积与质量、裸鼠肿瘤组织Ki67阳性比升高(P<0.05),细胞miR-376c-3p相对表达、Bax/Bcl-2与凋亡率、裸鼠肿瘤组织TUNEL阳性比降低(P<0.05);miR-376c-3p mimics组细胞增殖率与集落形成率、肿瘤体积与质量、裸鼠肿瘤组织Ki67阳性比降低(P<0.05),细胞miR-376c-3p相对表达、Bax/Bcl-2与凋亡率、裸鼠肿瘤组织TUNEL阳性比升高(P<0.05);阴性对照组各指标无明显变化(P>0.05)。结论抑制miRNA-376c-3p可削弱ccRCC细胞增殖及集落生成活性,促进其凋亡,并在裸鼠体内抑制其移植瘤生长。 展开更多
关键词 miRNA-376c-3p 肾透明细胞癌 肾细胞 肿瘤细胞 生长
下载PDF
上一页 1 2 14 下一页 到第
使用帮助 返回顶部